Michelle Gilson

Director - CNS Marketing at Sunovion Pharmaceuticals - Marlborough, Massachusetts, US

Michelle Gilson's Colleagues at Sunovion Pharmaceuticals
Emily Adcock

Associate Director, Meeting & Event Services

Contact Emily Adcock

Claudia Hernandez

Director Global Regulatory Affairs

Contact Claudia Hernandez

Theresa Jolivette

Senior Director, Federal Government Affairs

Contact Theresa Jolivette

Kenta Nakamura

Associate Director, Regenerative and Cellular Medicine

Contact Kenta Nakamura

Julie Chaves

Director, Payroll Administration

Contact Julie Chaves

Marc Wiedenmann

Associate Director, Patient Experience

Contact Marc Wiedenmann

Edward Coverdale

Sr. Director FP&A - Strategic Finance Decision Support

Contact Edward Coverdale

View All Michelle Gilson's Colleagues
Michelle Gilson's Contact Details
HQ
(508) 481-6700
Location
Company
Sunovion Pharmaceuticals
Michelle Gilson's Company Details
Sunovion Pharmaceuticals logo, Sunovion Pharmaceuticals contact details

Sunovion Pharmaceuticals

Marlborough, Massachusetts, US • 1042 Employees
Major Drugs

This page is no longer active or monitored. We are now Sumitomo Pharma America (SMPA), a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us!⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀ ==== Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. Sunovion’s spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. The Company has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with serious neurological and psychiatric conditions. Sunovion’s track record of discovery, development and commercialization of important therapies has included Latuda® (lurasidone HCI), Aptiom® (eslicarbazepine acetate) Lonhala® Magnair® (glycopyrrolate), and, most recently, KYNMOBI® (apomorphine HCI) sublingual film. Headquartered in Marlborough, MA Sunovion is an indirect, wholly owned subsidiary of Sumitomo Pharma Co., Ltd. Sunovion Pharmaceuticals Canada, Inc., based in Mississauga, Ontario, is a wholly-owned direct subsidiary of Sunovion Pharmaceuticals Inc. Find more information at www.sunovion.com and connect on Twitter and Facebook @Sunovion. LATUDA is a registered trademark of Sumitomo Pharma Co., Ltd. APTIOM is used under license from BIAL. KYNMOBI is a registered trademark of Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR is a registered trademarks of Sunovion Pharmaceuticals Inc. © 2023 Sunovion Pharmaceuticals Inc. To view our community guidelines, see here: bit.ly/3CozDLX

Neurological Care Pharmaceutical Research Psychiatric Treatments Biopharmaceuticals Medical Innovation Scientific Advancement Therapeutic Activities Drug Development And Manufacturing Clinical Trials Patient Advocacy
Details about Sunovion Pharmaceuticals
Frequently Asked Questions about Michelle Gilson
Michelle Gilson currently works for Sunovion Pharmaceuticals.
Michelle Gilson's role at Sunovion Pharmaceuticals is Director - CNS Marketing.
Michelle Gilson's email address is ***@sunovion.com. To view Michelle Gilson's full email address, please signup to ConnectPlex.
Michelle Gilson works in the Major Drugs industry.
Michelle Gilson's colleagues at Sunovion Pharmaceuticals are Emily Adcock, Claudia Hernandez, Theresa Jolivette, Kenta Nakamura, Julie Chaves, Marc Wiedenmann, Edward Coverdale and others.
Michelle Gilson's phone number is (508) 481-6700
See more information about Michelle Gilson